BioSpace News Archive

Israel’s Accelerated Evolution Biotechnologies Claims a Cure for Cancer

Accelerated Evolution Biotechnologies(AEBi)’s claims to have found a cure for cancer are, appropriately, being met with global skepticism. Learn more about it here.

January 30, 2019
·
3 min read
·
Mark Terry
Career Advice

4 Reasons Why You Didn’t Get the Job

When you are constantly hearing, “Thank you for your time, but we went with another candidate,” or you’re regularly submitting applications online, but not ever getting a response back, it can be frustrating.

January 30, 2019
·
3 min read
·
Porschia Parker
Job Trends

ColdQuanta Sponsors Research at University of Wisconsin to Accelerate Neutral Atom Quantum Computer Commercialization

Executive Chairman Tim Day to Present at Photonics West Marketplace Seminar

January 30, 2019
·
3 min read
Santen Hosts Event to Raise Public Awareness of Importance of Continued Glaucoma Treatment Prior to Sponsoring World Glaucoma Week in March

As part of its efforts to raise public awareness of glaucoma, Santen Pharmaceutical Co., Ltd., based in Osaka, will sponsor glaucoma awareness-raising activities to be conducted around the world during the World Glaucoma Week, from Sunday, March 10, to Saturday, March 16, 2019.

January 30, 2019
·
3 min read
Drug Development

Genentech to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer’s Disease (AD) - Other Company Programs in AD Continue

Genentech, a member of the Roche Group, announced the decision to discontinue CREAD 1 and CREAD 2 Phase III studies of the investigational anti-beta-amyloid molecule crenezumab in people with early sporadic Alzheimer’s disease.

January 30, 2019
·
6 min read
Business

Q4 Incl. Full Year Report 2018

2018 was a pivotal year for Orexo

January 30, 2019
·
7 min read
Business

Peroxfarma’s Goal is to Give Everyone an Extra Dose of Health

Peroxfarma, the company behind the Epaplus line of nutritional supplements, wants to give everyone an “extra dose” of health.

January 30, 2019
·
2 min read
Drug Development

BioInvent Receives FDA Orphan Designation for BI-1206 for Mantle Cell Lymphoma

BioInvent is currently investigating this combination in Phase I/IIa study

January 30, 2019
·
3 min read
University of Exeter: Common Gene Disorder Causes Serious “Stealth” Disease, but Could Be Easily Treated

The western world’s most common genetic disorder, hemochromatosis, causes far higher levels of serious disease and disability than previously thought, despite being easy to detect and treat.

January 30, 2019
·
3 min read
Dartford and Gravesham NHS Trust Uses Current Remote Patient Monitoring to Reduce Hospital Readmissions, Emergency Department and In-Home Therapy Visits

Facing severe winter pressures and workforce shortages, an NHS trust deployed Current’s wireless, wearable platform to deliver a proactive, safe and secure patient healthcare model

January 30, 2019
·
4 min read